Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Extracellular Vesicles & Nanoparticle-based Therapeutics Europe 2023

Abstract



NanoFCM Brings Flow Cytometry Capabilities to the Nanoscale!

Natalia Gebara, , NanoFCM Co., Ltd.

Conventional flow cytometers often struggle to meet the sensitivity requirements for the analysis of nanoscale particles, such as exosomes, nanomedicine, and viruses. To meet this challenge, NanoFCM has developed the NanoAnalyzer, a dedicated nano-flow cytometry platform, which offers a flexible and high-throughput solution for sub-micron analysis. By using the NanoAnalyzer, single-particle characterization can be achieved which simultaneously measures the side scatter (40 -1000nm) and fluorescent properties of particles. The size detection of the NanoAnalyzer favorably compares to electron microscopy and covers the entire size range of EVs, offering a detailed analysis of size, concentration, and biochemical properties by direct correlation of the physical and phenotypic data.  It is by combination of all these properties that the NanoAnalyzer is an ideal next-generation technique/ instrument for the analysis of EVs.


Add to Calendar ▼2023-11-13 00:00:002023-11-14 00:00:00Europe/LondonExtracellular Vesicles and Nanoparticle-based Therapeutics Europe 2023Extracellular Vesicles and Nanoparticle-based Therapeutics Europe 2023 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com